Topic: Vaccine Production
Merck's expansion of Gardasil production in Virginia and now in North Carolina means $1.68 billion in investments and 525 new jobs.
Takeda seeks delay of Velcade copy approvals, a new bid for Sinovac appears, Samsung and Biogen's Humira copycat gets EMA support.
Takeda has been eyeing India’s vaccine market since at least 2015, and the idea has come to fruition in the form of two licensing deals.
Bavarian Nordic has licensed a cell line from Valneva to help it manufacture vaccines based on its modified vaccinia Ankara vaccine platform.
With stellar vaccine sales for GlaxoSmithKline and Bexsero, GSK is building a $175 million plant in Germany to expand production of the meningococcal B shot.